or Try an Advanced Search...

    Technical Analysis for PSTX - Poseida Therapeutics, Inc.

    Grade Last Price % Change Price Change
    D 2.47 4.22% 0.10
    PSTX closed up 4.22 percent on Friday, November 1, 2024, on 58 percent of normal volume.
    Earnings due: Nov 7
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical PSTX trend table...
    Date Alert Name Type % Chg
    Bollinger Band Squeeze Range Contraction 0.00%
    Hammer Candlestick Bullish 4.22%
    Bollinger Band Squeeze Range Contraction 4.22%
    Stochastic Reached Oversold Weakness 4.22%
    BB Squeeze + Lower Band Touch Range Contraction 4.22%
    Down 3 Days in a Row Weakness 4.22%
    Lower Bollinger Band Touch Weakness 4.22%
    Oversold Stochastic Weakness 4.22%
    Bollinger Band Squeeze Range Contraction 3.78%
    Hammer Candlestick Bullish 0.82%
    Older End-of-Day Signals for PSTX ...

       Recent Intraday Alerts

    Alert Time
    Rose Above 10 DMA about 19 hours ago
    Possible NR7 about 20 hours ago
    10 DMA Resistance about 21 hours ago
    Up 3% about 21 hours ago
    60 Minute Opening Range Breakout about 21 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    PSTX Chart by TradingView
    Basic chart:

    Profile

    Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in 2014 and is headquartered in San Diego, CA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Biopharmaceutical Clinical Medicine Life Sciences Solid Tumors Immune System Cancer Treatment Lymphoma Leukemia Chimeric Antigen Receptor T Cell Hematological Malignancies Chimeric Antigen Receptor Cellectis

    Is PSTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 24 Poseida Therapeutics to Present New Preclinical Data Supporting Non-Viral Gene Editing with P-KLKB1-101 for the Treatment of Hereditary Angioedema
    Oct 17 Poseida Therapeutics Announces Nomination of New CAR-T Development Candidate Under Collaboration with Roche
    Oct 15 MaxCyte Appoints Cynthia Collins to its Board of Directors
    Oct 3 Poseida Therapeutics Named to Newsweek's List of the Top 200 America's Most Loved Workplaces for 2024
    Sep 30 Poseida: Interim P-BCMA-ALLO1 Data Bodes Well For Phase 1B Advancement
    Sep 27 Poseida struggles post market after phase 1 multiple myeloma CAR-T therapy data
    Sep 27 Poseida Therapeutics Reports Positive Interim Phase 1 Results for Allogeneic CAR-T Therapy P-BCMA-ALLO1 with High Overall Response Rates in Heavily Pretreated Relapsed/Refractory Multiple Myeloma Patients
    Sep 17 FDA grants RMAT to Poseida’s CAR-T cell therapy P-BCMA-ALLO1
    Sep 16 Poseida Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for P-BCMA-ALLO1 to Treat Relapsed/Refractory Multiple Myeloma
    Sep 9 Poseida Therapeutics: An Underappreciated Company Continuing To Shape Up Well In 2024
    See more PSTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.27
    52 Week Low 1.87
    Average Volume 439,920
    200-Day Moving Average 2.98
    50-Day Moving Average 2.76
    20-Day Moving Average 2.49
    10-Day Moving Average 2.45
    Average True Range 0.13
    RSI (14) 42.86
    ADX 23.07
    +DI 16.06
    -DI 22.63
    Chandelier Exit (Long, 3 ATRs) 2.31
    Chandelier Exit (Short, 3 ATRs) 2.70
    Upper Bollinger Bands 2.63
    Lower Bollinger Band 2.36
    Percent B (%b) 0.42
    BandWidth 10.79
    MACD Line -0.10
    MACD Signal Line -0.11
    MACD Histogram 0.0103
    Fundamentals Value
    Market Cap 236.19 Million
    Num Shares 95.6 Million
    EPS -1.54
    Price-to-Earnings (P/E) Ratio -1.60
    Price-to-Sales 6.92
    Price-to-Book 2.78
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.61
    Resistance 3 (R3) 2.59 2.54 2.58
    Resistance 2 (R2) 2.54 2.50 2.54 2.57
    Resistance 1 (R1) 2.50 2.48 2.52 2.52 2.57
    Pivot Point 2.45 2.45 2.46 2.45 2.45
    Support 1 (S1) 2.41 2.41 2.43 2.43 2.37
    Support 2 (S2) 2.36 2.39 2.36 2.37
    Support 3 (S3) 2.32 2.36 2.36
    Support 4 (S4) 2.34